Kaku N - Search Results

1

Impact of Education on Inappropriate Antibiotic Prescription for Respiratory Tract Infection Based on Physicians' Justifications: A Web-Based Survey in Japan.

Kudoh R, Komiya K, Kaku N, Shindo Y, Hayashi T, Kasahara K, Oishi T, Ishiwada N, Ito M, Yotsuyanagi H, Hasegawa N, Tateda K, Hotomi M, Yanagihara K. Kudoh R, et al. Among authors: kaku n. Antibiotics (Basel). 2024 Oct 30;13(11):1022. doi: 10.3390/antibiotics13111022. Antibiotics (Basel). 2024. PMID: 39596717 Free PMC article.

2

Azithromycin attenuates lung inflammation in a mouse model of ventilator-associated pneumonia by multidrug-resistant Acinetobacter baumannii.

Yamada K, Yanagihara K, Kaku N, Harada Y, Migiyama Y, Nagaoka K, Morinaga Y, Nakamura S, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Hasegawa H, Mikamo H, Kohno S. Yamada K, et al. Among authors: kaku n. Antimicrob Agents Chemother. 2013 Aug;57(8):3883-8. doi: 10.1128/AAC.00457-13. Epub 2013 Jun 3. Antimicrob Agents Chemother. 2013. PMID: 23733468 Free PMC article.

3

In vivo efficacy of biapenem with ME1071, a novel metallo-β-lactamase (MBL) inhibitor, in a murine model mimicking ventilator-associated pneumonia caused by MBL-producing Pseudomonas aeruginosa.

Yamada K, Yanagihara K, Kaku N, Harada Y, Migiyama Y, Nagaoka K, Morinaga Y, Nakamura S, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Hasegawa H, Yasuoka A, Kohno S. Yamada K, et al. Among authors: kaku n. Int J Antimicrob Agents. 2013 Sep;42(3):238-43. doi: 10.1016/j.ijantimicag.2013.05.016. Epub 2013 Jul 26. Int J Antimicrob Agents. 2013. PMID: 23891525

4

Active Surveillance of Methicillin-Resistant Staphylococcus aureus Using a Fully Automated Molecular Test in an Emergency Medical Center.

Morinaga Y, Yamano S, Akamatsu N, Kaku N, Nagaoka K, Migiyama Y, Harada Y, Hosogaya N, Yamamoto Y, Tasaki O, Yanagihara K, Kohno S. Morinaga Y, et al. Among authors: kaku n. Jpn J Infect Dis. 2015;68(5):376-80. doi: 10.7883/yoken.JJID.2014.352. Epub 2015 Mar 13. Jpn J Infect Dis. 2015. PMID: 25766607 Free article.

5

Pseudomonas aeruginosa Bacteremia among Immunocompetent and Immunocompromised Patients: Relation to Initial Antibiotic Therapy and Survival.

Migiyama Y, Yanagihara K, Kaku N, Harada Y, Yamada K, Nagaoka K, Morinaga Y, Akamatsu N, Matsuda J, Izumikawa K, Kohrogi H, Kohno S. Migiyama Y, et al. Among authors: kaku n. Jpn J Infect Dis. 2016;69(2):91-6. doi: 10.7883/yoken.JJID.2014.573. Epub 2015 Jun 12. Jpn J Infect Dis. 2016. PMID: 26073727 Free article.

6

Antimicrobial and immunomodulatory effects of tedizolid against methicillin-resistant Staphylococcus aureus in a murine model of hematogenous pulmonary infection.

Kaku N, Morinaga Y, Takeda K, Kosai K, Uno N, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K. Kaku N, et al. Int J Med Microbiol. 2016 Sep;306(6):421-8. doi: 10.1016/j.ijmm.2016.05.010. Epub 2016 May 19. Int J Med Microbiol. 2016. PMID: 27259840

7

Clinical application of a ligation-independent pathway of multiplex ligation-dependent probe amplification for the determination of quinolone susceptibility of Streptococcus pneumoniae.

Uno N, Araki N, Kaku N, Kosai K, Hasegawa H, Yanagihara K. Uno N, et al. Among authors: kaku n. J Microbiol Methods. 2016 Sep;128:13-15. doi: 10.1016/j.mimet.2016.06.024. Epub 2016 Jun 23. J Microbiol Methods. 2016. PMID: 27343683

8

TNF-α inhibits the growth of Legionella pneumophila in airway epithelial cells by inducing apoptosis.

Kawamoto Y, Morinaga Y, Kimura Y, Kaku N, Kosai K, Uno N, Hasegawa H, Yanagihara K. Kawamoto Y, et al. Among authors: kaku n. J Infect Chemother. 2017 Jan;23(1):51-55. doi: 10.1016/j.jiac.2016.09.010. Epub 2016 Nov 17. J Infect Chemother. 2017. PMID: 27865699

9

Efficacy and pharmacokinetics of ME1100, a novel optimized formulation of arbekacin for inhalation, compared with amikacin in a murine model of ventilator-associated pneumonia caused by Pseudomonas aeruginosa.

Kaku N, Morinaga Y, Takeda K, Kosai K, Uno N, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K. Kaku N, et al. J Antimicrob Chemother. 2017 Apr 1;72(4):1123-1128. doi: 10.1093/jac/dkw517. J Antimicrob Chemother. 2017. PMID: 27999047

10

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas Aeruginosa.

Kosai K, Kaku N, Uno N, Saijo T, Morinaga Y, Imamura Y, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K. Kosai K, et al. Among authors: kaku n. Open Microbiol J. 2017 May 31;11:92-97. doi: 10.2174/1874285801711010092. eCollection 2017. Open Microbiol J. 2017. PMID: 28694882 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters